Oligonucleotide-based microarray for DNA methylation analysis: Principles and applications

Journal of Cellular Biochemistry

Volumn 88, Issue 1, 2003, Pages 138-143

  Shi, Huidong ^a   Maier, Sabine ^b   Nimmrich, Inko ^b   Yan, Pearlly S ^a   Caldwell, Charles W ^a   Olek, Alexander ^b   Huang, Tim Hui Ming ^a  

^a University of Missouri   (United States)

^b EPIGENOMICS AG   (Germany)

Author keywords

Cancer; CpG islands; DNA methylation; Oligonucleotide microarray

Indexed keywords

COMPLEMENTARY DNA; DNA; MESSENGER RNA;

CELL GROWTH; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE SILENCING; HUMAN; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TUMOR CELL;

CPG ISLANDS; DNA METHYLATION; GENE SILENCING; HUMANS; LYMPHOMA, NON-HODGKIN; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES; POLYMERASE CHAIN REACTION;

EID: 12244286046     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10313     Document Type: Review

References (24)

1. Adorján P, Distler J, Lipscher E, Model F, Muller J, Pelet C, Braun A, Florl AR, Gutig D, Grabs G, Howe A, Kursar M, Lesche R, Leu E, Lewin A, Maier S, Muller V, Otto T, Scholz C, Schulz WA, Seifert HH, Schwope I, Ziebarth H, Berlin K, Piepenbrock C, Olek A. 2002. Tumor class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res 30:e21.
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Jr., Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Staudt LM. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
3. Antequera F, Boyes J, Bird A. 1990. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62:503-514.
4. Bird A. 1986. CpG-rich islands and the function of DNA methylation. Nature 321:209-213.
5. Bird A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev 16:6-21.
6. Clark SJ, Harrison J, Paul CL, Frommer M. 1994. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22:2990-2997.
7. Clarke PA, te Poele R, Wooster R, Workman P. 2001. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: Progress and potential. Biochem Pharmacol 62:1311-1336.
8. Esteller M, Corn PG, Baylin SB, Herman JG. 2001. A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229.
9. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci 89:1827-1831.
10. Gitan RS, Shi H, Yan PS, Huang TH-M. 2002. Methylation-specific oligonucleotide microarray: A new potential for high-throughput methylation analysis. Genome Res 12: 158-164.
11. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. 1999. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
12. Jones PA, Baylin SB. 2002. The fundamental role of epigenetic events in cancer. Cancer Cell 3:415-428.
13. Jones PA, Laird PW. 1999. Cancer epigenetics comes of age. Nature Genet 21:163-167.
14. Lyon MF. 1999. Imprinting and X-chromosome inactivation. Results Probl Cell Differ 25:73-90.
15. Melki JR, Vincent PC, Clark SJ. 1999. Cancer-specific region of hypermethylation identified within the HIC1 putative tumour suppressor gene in acute myeloid leukaemia. Leukemia 13:877-883.
16. Model F, Adorján P, Olek A, Piepenbrock C. 2001. Feature selection for DNA methylation based cancer classification. Bioinformatics 17:S157-S164.
17. Rice JC, Massey-Brown KS, Futscher BW. 1998. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 17:1807-1812.
18. Santini V, Kantarjian HM, Issa JP. 2001. Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications. Ann Intl Med 134:573-586.
19. Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, Costello JF, Lang JC, Eng C, Li B, Wright FA, Caligiuri MA, Plass C. 2001. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 13:1413-1419.
20. Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, Frommer M, Clark SJ. 1997. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 57:2229-2237.
21. Wei SH, Chen C-M, Strathdee G, Harnsomburana J, Shyu CR, Rahmatpanah F, Shi H, Ng SW, Yan PS, Nephew KP, Brown R, Huang TH-M. 2002. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clin Cancer Res 8:2246-2252.
22. Widschwendter M, Jones PA. 2002. The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. Clin Cancer Res 8:17-21.
23. Yan P, Perry M, Laux D, Asare A, Caldwell C, Huang T-M. 2000. CpG island arrays: An application toward deciphering epgienetic signatures of breast cancer. Clin Cancer Res 6:1432-1438.
24. Yan PS, Chert Chen C-M, Shi H, Rahmatpanah F, Wei SH, Caldwell CW, Huang TH-M. 2001. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res 61:8375-8380.